Rare diseases might be rare, but collectively they are common. And with over 7,000 rare diseases worldwide, orphan drug designations are becoming increasingly common too. Here is a list of the 10 indications with the most orphan drug designations in the EU (the register of designation Orphan Medicinal Products in the EU can also be found here on the European Commission website).
|Rank||Indication||Number of EU designations|
|1||Acute myeloid leukaemia||45|
|8||Renal cell carcinoma||27|
|10||Chronic lymphocytic leukaemia||20|
If you want to know more about innovation and strategy in the orphan drug market, you might be interested in attending the World Orphan Drug Congress Asia, 18-19 June 2013, Singapore, or the 4th World Orphan Drug Congress Europe, in Geneva on the 14th November 2013.
YOU MIGHT BE INTERESTED IN: Top 8 Best-Selling Orphan Drugs Approved and Launched During 2012